Facebook
Instagram
Pinterest
Reddit
Tumblr
Twitter
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 129
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #219: Trump Admin. Vetoed Compass Priority Voucher; Ibogaine in Focus; Definium Sued by Former Vendor; Psychedelics Feature in Epstein Files
Center for MINDS: Bruce Damer on Why We Need Psychedelic-Catalysed Innovation
The Psychedelic News Feed: January 26 – Febraury 1, 2026
Q3 2025: Oregon Psilocybin Services Update
Patient Safety After a Death: What Transparency Can and Cannot Do
First Patient Dosed in Small Pharma’s Drug Interaction Study
Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement
Revive Therapeutics Ltd. Expands Life Offering to Quebec
MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT
Israeli Based Biotech Company Clearmind Medicine Inc’s CEO, Dr. Adi Zuloff-Shani,...
Psychedelics Weekly – Proposition 122 in Action, The Economics of Psychedelics,...
FILAMENT HEALTH AND PSYENCE ANNOUNCE WORLDWIDE LICENSING AGREEMENT OF PSILOCYBIN CAPSULE...
PsyBio Therapeutics Takes Initial Step to Help Protect the Sonoran Desert...
MIND CURE ENTERS INTO BINDING LETTER OF INTENT WITH LNG ENERGY...
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets...
1
...
128
129
130
...
307
Page 129 of 307
